Codify — Article

Medical Foods and Formulas Access Act of 2025: Federal coverage mandates

Establishes a statutory definition of “medically necessary food” and requires Medicare, Medicaid, CHIP, and FEHBP to cover prescribed medical foods, vitamins, and single amino acids for specified digestive and metabolic disorders.

The Brief

The Medical Foods and Formulas Access Act of 2025 adds a new, statutory category—“medically necessary food”—to the Social Security Act and requires federal health programs to cover these products and the equipment and supplies needed to administer them. The bill directs Medicare, Medicaid, CHIP, and the Federal Employee Health Benefits Program (FEHBP) to provide coverage for prescribed specialty formulas, vitamins, and individual amino acids when used to manage specified digestive and inherited metabolic disorders, with program-specific effective dates and payment rules.

This matters because it converts an often-fragmented patchwork of coverage into an explicit federal entitlement for people with clinically defined needs, potentially improving access for infants and adults with life‑threatening metabolic conditions. At the same time the bill raises budgetary and implementation questions: it creates a new mandated benefit for states, prescribes an initial Medicare payment approach, and leaves significant definitional and administrative discretion to HHS — all of which will shape patient access and program costs.

At a Glance

What It Does

The bill creates a statutory definition of “medically necessary food” and adds that category as a covered item under Medicare, Medicaid, CHIP, and FEHBP, including necessary administration supplies and equipment. It sets a Medicare payment mechanism (80% of the lesser of actual charge or a new fee schedule) and enumerates covered disease categories while excluding broad diet or lifestyle foods.

Who It Affects

Directly affects beneficiaries with inherited metabolic disorders, malabsorption syndromes, immune-mediated food allergies, and certain inflammatory GI conditions; state Medicaid programs (which must classify this as a mandatory benefit); federal payors (Medicare, CHIP, FEHBP); and manufacturers and suppliers of specialty formulas and amino acid products.

Why It Matters

This is the first federal statutory attempt to harmonize coverage of specialty medical foods across major public payors, reducing reliance on variable state and private plan policies. It will likely pressure private plans and influence market pricing, supplier contracting, and program budgets.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

The core legal change is an insertion into section 1861 of the Social Security Act of a new, detailed definition of “medically necessary food.” The bill defines the term narrowly by purpose and form: the product must be specially formulated or processed (not a naturally occurring food in its natural state), prescribed or ordered by an authorized clinician for dietary management of a listed disease or condition, intended for oral or enteral feeding, and used under medical direction for a patient receiving ongoing medical care. The definition names product types—low‑protein modified food products, amino acid preparations, modified fats, nutritional formulas, vitamins, and individual amino acids—and excludes categories such as diet/weight‑loss products, foods marketed as gluten‑free, and diabetes management foods, while leaving an open slot for further exclusions by the Secretary of HHS.

On Medicare, the bill amends the statutory list of covered items to include medically necessary food plus the equipment and supplies needed to administer it (subject to a carve‑out where Part B already covers those supplies). For payment, Congress directs Medicare to pay 80 percent of the lesser of the actual charge or an HHS fee schedule to be established for these items.

That Medicare change applies to items furnished three years after enactment, giving HHS time to design a fee schedule and payment processes.For Medicaid, the bill inserts medically necessary food into the list of mandatory Medicaid benefits and makes explicit that benchmark and benchmark‑equivalent benefit packages cannot be offered unless they include medically necessary food and related administration supplies. It also amends cost‑limit language to ensure these supplies are treated consistently, and it delays full application for two years with a state‑legislation exception so states that need statutory changes have time to comply.The bill similarly amends CHIP to require coverage of medically necessary food for targeted low‑income children (with a one‑year delay and similar state‑legislation timing exception) and amends FEHBP to require carriers to cover medically necessary food in contracts (applying to contract years beginning one year after enactment).

Finally, the statute contains non‑preemption language preserving state laws that provide greater coverage, a “sense of Congress” urging private plans to follow suit, and an explicit clause stating coverage can include combinations of foods and the supplies to administer them when prescribed together.

The Five Things You Need to Know

1

The bill inserts a new statutory definition of “medically necessary food” at section 1861(nnn) of the Social Security Act that limits covered items to specially formulated or processed products used under medical direction for specific diseases.

2

Medicare reimbursement for medically necessary food is set at 80% of the lesser of actual charge or an HHS fee schedule; that payment rule applies to items furnished three years after enactment.

3

Medicaid must treat medically necessary food as a mandatory covered benefit; states may not offer benchmark or benchmark‑equivalent plans unless such coverage is included.

4

CHIP coverage of medically necessary food becomes mandatory one year after enactment (with the usual state‑legislation timing exception); Medicaid’s requirement phases in after two years with a similar exception.

5

The definition expressly excludes diet/weight‑loss products, foods marketed as gluten‑free, and diabetes management foods, while allowing the Secretary to add other exclusions.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 1

Short title

Names the bill the “Medical Foods and Formulas Access Act of 2025.” This is purely caption language and does not affect substantive operation.

Section 3(a) — Medicare coverage (amendment to 1861(s)(2))

Adds medically necessary food as a Medicare-covered item

Amends the Medicare statute to add medically necessary food to the list of items that Medicare can cover and clarifies that necessary administration equipment and supplies are also covered unless those supplies would already fall under Part B without the new subparagraph. Practically, that creates a new Medicare benefit category that HHS must administer and pay for once the effective date arrives.

Section 3(a)(2) — Definition (new 1861(nnn))

Defines ‘medically necessary food’ and lists covered conditions and exclusions

Provides a multi-part definition that limits coverage to specially formulated or processed products prescribed by an authorized clinician for dietary management of a covered disease or condition. The statute enumerates covered condition groups—multiple inherited metabolic disorders, malabsorption from GI or hepatic/pancreatic disease, immune‑mediated and non‑IgE food allergies, and inflammatory GI conditions—and creates a catch‑all allowing the Secretary to add conditions. It also lists explicit exclusions (e.g., gluten‑free marketed foods, diabetes management foods, general diet products) and defines ‘low protein modified food product’ narrowly so naturally low‑protein foods aren’t swept in.

4 more sections
Section 3(a)(3) — Medicare payment and effective date

Sets initial Medicare payment approach and timing

Directs Medicare payment at 80 percent of the lesser of actual charge or an HHS fee schedule established for medically necessary food, rather than folding these items into existing durable medical equipment or drug payment systems. The coverage and payment provisions for Medicare items take effect three years after enactment, intentionally giving HHS time to design the fee schedule and billing rules.

Section 3(b) — Medicaid changes

Makes medically necessary food a mandatory Medicaid benefit and limits benchmark plans

Inserts medically necessary food into the Medicaid mandatory benefits list and adjusts related cost‑limit language so administration supplies are included. Critically, it prevents states from offering benchmark or benchmark‑equivalent coverage unless those benefit packages include medically necessary food, which curbs a common route for narrower benefit design. The Medicaid obligations take effect two years after enactment, with a standard exception where state statutory change is required.

Sections 3(c)–(d) — CHIP and FEHBP

Extends requirement to CHIP and federal employee plans

Requires child health assistance under CHIP to include medically necessary food and requires FEHBP contracts to cover medically necessary food; CHIP coverage becomes mandatory one year after enactment (subject to state‑law timing exceptions), and FEHBP changes apply to contract years beginning one year after enactment. These provisions bring both children’s coverage and federal employee plans into alignment with Medicare/Medicaid rules, though the bill does not prescribe FEHBP payment mechanics.

Sections 3(e)–(g) — Sense of Congress, nonpreemption, combinations

Nonbinding guidance and guardrails for state and private coverage

Includes a nonbinding sense of Congress urging private health plans to provide similar coverage. It preserves state laws that offer broader coverage, so states may go beyond federal minimums. The bill also clarifies that coverage may include combinations of medically necessary foods and the supplies to administer them when prescribed together, closing a potential gap where combination regimens could otherwise be denied.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Infants and children diagnosed through newborn screening with inborn errors of metabolism: The statute explicitly lists many metabolic disorders and makes formulas and amino acid products a covered category, improving the prospect of timely access to life‑sustaining nutrition.
  • Adults with short bowel syndrome, pancreatic insufficiency, or other malabsorption syndromes: The law covers enteral and oral medical formulas and related supplies, reducing the risk that payors will require tube feeding or deny needed products.
  • Clinicians (pediatricians, metabolic specialists, gastroenterologists): The bill creates a clearer prescribing pathway and reduces the administrative friction of seeking coverage on a case‑by‑case basis.
  • Manufacturers and specialty product suppliers: A statutory coverage mandate across major federal payors increases the addressable market and creates predictable public payor demand for certain categories of formulas and amino acids.

Who Bears the Cost

  • Federal payors and the Medicare Trust Fund: Medicare must pay under the new statutory payment rule; expansion of covered items will increase program outlays and affect budgeting.
  • State Medicaid programs and state budgets: Medicaid is required to cover these items as a mandatory benefit, generating direct costs for states and potential pressure on state budgets unless matched by federal funds or offsetting changes.
  • FEHB carriers and potentially employer plans: FEHBP carriers must include coverage in contracts; while private plans are only urged (not required) to follow, market and regulatory pressure may shift costs onto commercial carriers and employer sponsors.
  • HHS and state Medicaid agencies: Agencies must develop fee schedules, claims and coding guidance, and adjudication policies — creating administrative costs and operational challenges during the multi‑year phase‑in.

Key Issues

The Core Tension

The bill balances two legitimate goals—ensuring life‑saving access to specialized medical foods for narrowly defined clinical groups and restraining public program costs and scope—but it does so by creating a statutory entitlement whose boundaries, price, and administrative operation are left largely to HHS and state agencies; the central dilemma is how to draw a tight enough definition to prevent benefit expansion and abuse while keeping it broad and flexible enough to guarantee clinically necessary access in diverse cases.

The bill solves an access problem by creating a statutory entitlement for a narrowly defined set of products, but the text leaves substantial room for administrative interpretation that will drive real‑world access. The definition repeats policy choices that are easy to litigate: “specially formulated and processed” versus naturally occurring foods, the requirement that use be “under medical direction,” and the list of included and excluded conditions create threshold disputes about what qualifies as a medical necessity.

Those disputes will fall to HHS and state Medicaid agencies to resolve through rulemaking, guidance, and claims adjudication.

Payment and implementation mechanics are another tension point. Medicare’s 80 percent payment rule tied to an HHS fee schedule delegates price‑setting to the agency but does not specify how the fee schedule will relate to existing pharmacy or DME channels, nor how suppliers will bill.

That creates uncertainty for manufacturers and providers and an initial 3‑year gap where beneficiaries remain uninsured for these items under Medicare. Staggered effective dates across programs (Medicare 3 years, Medicaid 2, CHIP 1, FEHBP for next contract year) will produce a patchwork of coverage timing, administrative complexity for multi‑payer billing, and short‑term inequities in access.

The statute also draws a line excluding broad classes of foods (e.g., gluten‑free marketed foods, diabetes management foods, weight‑loss products), but enforcement depends on product classification and clinical documentation. The Secretary’s discretionary authority to add exclusions and conditions gives HHS gatekeeping power that could narrow or expand access depending on implementation choices, raising questions about transparency, appeals, and the role of clinical guidelines.

Finally, while the law explicitly allows oral formula access, it does not create a specific enforcement tool to prevent payors from mandating enteral routes or surgical interventions, leaving practical disputes about modality and prior authorization procedures unresolved.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.